|
US - Eli Lilly & Co (EL) completed its challenging tender offer to acquire all the outstanding common stock of ImClone Systems Inc (IS), a biotechnology company, for $## in cash per share, or a total value of $#.### bil. The…
|
| Credit & Investment Research |
|
|